Literature DB >> 12648065

A pooled analysis of karyotypic patterns, breakpoints and imbalances in 783 cytogenetically abnormal multiple myelomas reveals frequently involved chromosome segments as well as significant age- and sex-related differences.

Thérèse Nilsson1, Mattias Höglund, Stig Lenhoff, Lars Rylander, Ingemar Turesson, Jan Westin, Felix Mitelman, Bertil Johansson.   

Abstract

The cytogenetic features (ploidy, complexity, breakpoints, imbalances) were ascertained in 783 abnormal multiple myeloma (MM) cases to identify frequently involved chromosomal regions as well as a possible impact of age/sex. The series included MM patients from the Mitelman Database of Chromosome Aberrations in Cancer and from our own laboratory. Hyperdiploidy was most common, followed by hypodiploidy, pseudodiploidy and tri-/tetraploidy. Most cases were complex, with a median of eight changes per patient. The distribution of modal numbers differed between younger and older patients, but was not related to sex. No sex- or age-related differences regarding the number of anomalies were found. The most frequent genomic breakpoints were 14q32, 11q13, 1q10, 8q24, 1p11, 1q21, 22q11, 1p13, 1q11, 19q13, 1p22, 6q21 and 17p11. Breaks in 1p13, 6q21 and 11q13 were more common in the younger age group. The most frequent imbalances were + 9, - 13, + 15, + 19, + 11 and - Y. Trisomy 11 and monosomy 16 were more common among men, while -X was more frequent among women. Loss of Y as the sole change and + 5 were more common in elderly patients, and - 14 was more frequent in the younger age group. The present findings strongly suggest that some karyotypic features of MM are influenced by endogenous and/or exogenous factors.

Entities:  

Mesh:

Year:  2003        PMID: 12648065     DOI: 10.1046/j.1365-2141.2003.04221.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  16 in total

1.  Age and aging in blood disorders: multiple myeloma.

Authors:  Sonja Zweegman; Antonio Palumbo; Sara Bringhen; Pieter Sonneveld
Journal:  Haematologica       Date:  2014-07       Impact factor: 9.941

2.  Conventional Cytogenetics and Interphase Fluorescence In Situ Hybridization Results in Multiple Myeloma: A Turkey Laboratory Analysis of 381 Cases.

Authors:  Cigdem Aydin; Turgay Ulas; Ceren Hangul; Orhan Kemal Yucel; Utku Iltar; Ozan Salim; Deniz Ekinci; Sibel Berker Karauzum
Journal:  Indian J Hematol Blood Transfus       Date:  2019-10-25       Impact factor: 0.900

Review 3.  Management of Newly Diagnosed Elderly Multiple Myeloma Patients.

Authors:  Crystal Antoine-Pepeljugoski; Marc Justin Braunstein
Journal:  Curr Oncol Rep       Date:  2019-05-24       Impact factor: 5.075

4.  A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS.

Authors:  Wee Joo Chng; Scott A Van Wier; Gregory J Ahmann; Jerry M Winkler; Syed M Jalal; Peter Leif Bergsagel; Marta Chesi; Mike C Trendle; Martin M Oken; Emily Blood; Kim Henderson; Rafael Santana-Dávila; Robert A Kyle; Morie A Gertz; Martha Q Lacy; Angela Dispenzieri; Philip R Greipp; Rafael Fonseca
Journal:  Blood       Date:  2005-05-26       Impact factor: 22.113

5.  Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and beta-catenin.

Authors:  Junya Kuroda; Yuri Kamitsuji; Shinya Kimura; Eishi Ashihara; Eri Kawata; Yoko Nakagawa; Miki Takeuichi; Yoshihide Murotani; Asumi Yokota; Ruriko Tanaka; Michael Andreeff; Masafumi Taniwaki; Taira Maekawa
Journal:  Int J Hematol       Date:  2008-04-17       Impact factor: 2.490

6.  Tetraploidy is associated with poor prognosis at diagnosis in multiple myeloma.

Authors:  Surbhi Sidana; Dragan Jevremovic; Rhett P Ketterling; Nidhi Tandon; Patricia T Greipp; Linda B Baughn; Angela Dispenzieri; Morie A Gertz; Sundararajan Vincent Rajkumar; Shaji K Kumar
Journal:  Am J Hematol       Date:  2019-02-06       Impact factor: 10.047

7.  Deletions of CDKN2C in multiple myeloma: biological and clinical implications.

Authors:  Paola E Leone; Brian A Walker; Matthew W Jenner; Laura Chiecchio; Gianpaolo Dagrada; Rebecca K M Protheroe; David C Johnson; Nicholas J Dickens; Jose Luis Brito; Monica Else; David Gonzalez; Fiona M Ross; Selina Chen-Kiang; Faith E Davies; Gareth J Morgan
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

8.  A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experiments.

Authors:  Thierry Rème; Dirk Hose; John De Vos; Aurélien Vassal; Pierre-Olivier Poulain; Véronique Pantesco; Hartmut Goldschmidt; Bernard Klein
Journal:  BMC Bioinformatics       Date:  2008-01-11       Impact factor: 3.169

9.  Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine.

Authors:  Linping Hu; Kun Ru; Li Zhang; Yuting Huang; Xiaofan Zhu; Hanzhi Liu; Anders Zetterberg; Tao Cheng; Weimin Miao
Journal:  Biomark Res       Date:  2014-02-05

10.  Identification of novel pathogenic copy number aberrations in multiple myeloma: the Malaysian context.

Authors:  Pau Ni Ivyna Bong; Ching Ching Ng; Kah Yuen Lam; Puteri Jamilatul Noor Megat Baharuddin; Kian Meng Chang; Zubaidah Zakaria
Journal:  Mol Cytogenet       Date:  2014-04-01       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.